Cargando…
DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer
BACKGROUND: The Hippo pathway functions as a tumor suppressor pathway in human cancers, while dysfunction of the Hippo pathway is frequently observed in malignancies. Although YAP/TAZ activity is tightly controlled by the phosphorylation cascade of the MST-LATS-YAP/TAZ axis, it is still unclear why...
Autores principales: | Wang, Dehai, Li, Zhongbo, Li, Xin, Yan, Cheng, Yang, Huijie, Zhuang, Ting, Wang, Xiao, Zang, Yifeng, Liu, Ziping, Wang, Tianshi, Jiang, Rixia, Su, Peng, Zhu, Jian, Ding, Yinlu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275142/ https://www.ncbi.nlm.nih.gov/pubmed/35820928 http://dx.doi.org/10.1186/s13046-022-02410-5 |
Ejemplares similares
-
OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer
por: Yan, Cheng, et al.
Publicado: (2022) -
Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer
por: Wang, Tianshi, et al.
Publicado: (2023) -
USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis
por: Liu, Dongyi, et al.
Publicado: (2023) -
Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis
por: Mi, Yushuai, et al.
Publicado: (2022) -
RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis
por: Li, Zhongbo, et al.
Publicado: (2022)